"LEAP presents to civic, professional, educational, and religious organizations, as well as at public forums, but we target civic groups; Chambers of Commerce, Rotaries, Lions and Kiwanis Clubs, etc. The people in these organizations are conservative folks who mostly agree with the drug-warriors that we must continue the war on drugs at any cost. They are also very solid members of their communities; people who belong to civic organizations because they want the best for their locales. Every one of them will be voting in every election. Many are policy-makers and if they are not, they are the people who can pull the coat tails of policy-makers and say, "We have someone you must hear talk about drug policy."
"After making more than two-thousand presentations where LEAP calls for the government to "end prohibition and legalize all drugs--legalize them so we can control and regulate them and keep them out of the hands of our children," we have discovered that the vast majority of participants in those audiences agree with us. Even more amazing is that we are now attending national and international law-enforcement conventions where we keep track of all those we speak with at our exhibit booth. After we talk with them, only 6% want to continue the war on drugs, 14% are undecided, and an astounding 80% agree with LEAP that we must end drug prohibition. The most interesting thing about this statistic is that only a small number of that 80% realized any others in law enforcement felt the same." About LEAP - Law Enforcement Against Prohibition
*********************************************
premenstrual dysphoric disorder or PMDD
*************************************************
Mylan gets tenative FDA approval for generic Sarafem
Food and Drug Administration has granted tentative approval for the company's abbreviated new drug application for Fluoxetine capsules. The drug, which is used to treat premenstrual dysphoric disorder, is the generic version of Eli Lilly and Co.'s Sarafem,